A note on the number needed to treat

Controlled Clinical Trials

Volumn 20, Issue 5, 1999, Pages 439-447

  Lesaffre, Emmanuel ^a   Pledger, Gordon ^b  

^a Biostatistical Centre   (Belgium)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Absolute risk reduction; Anti epileptic drugs; Meta analysis; Number needed to treat

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; TOPIRAMATE;

ARTICLE; CALCULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; PATIENT; RISK; SAMPLE; SEIZURE; SIMULATION; STATISTICS;

ANTICONVULSANTS; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; EPILEPSY; FRUCTOSE; HUMANS; SAMPLE SIZE;

EID: 0032877437     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(99)00018-5     Document Type: Article

References (7)

1. Cook R.J., Sackett D.L. The number needed to treat. a clinically useful measure of treatment effect BMJ. 310:1995;452-454.
2. Elferinck A.J.A., Van Zwieten-Boot B.J. Analysis based on number needed to treat shows differences between drugs studies. BMJ. 314:1997;603.
3. Marson A.G., Kadir Z.A., Chadwick D.W. New antiepileptic drugs. a systematic review of their efficacy and tolerability BMJ. 313:1996;1169-1174.
4. Sharief M., Viteri C., Ben-Menachem E.et al. Double blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res. 25:1996;217-224.
5. Altman D.G. Confidence intervals for the number needed to treat. BMJ. 317:1998;1309-1312.
6. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. New York: Academic, 1985, p. 129.
7. S-Plus 4.5 User's Guide. Seattle: Data Analysis Products Division, MathSoft; 1998.